Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) and IMV (NASDAQ:IMV – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, profitability, risk, institutional ownership and analyst recommendations. Analyst Ratings This is a breakdown of current ratings and […]
Analysts expect that Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) will announce ($0.35) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Paratek Pharmaceuticals’ earnings, with the lowest EPS estimate coming in at ($0.35) and the highest estimate coming in at ($0.34). Paratek Pharmaceuticals reported earnings […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Wall Street brokerages expect Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) to post sales of $27.15 million for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Paratek Pharmaceuticals’ earnings, with the lowest sales estimate coming in at $27.00 million and the highest estimate coming in at $27.30 million. Paratek Pharmaceuticals reported […]